Trial Profile

A Phase 2, Multi-center, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy and Safety of PL9643 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 23 Nov 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Nov 2023 Primary endpoint has not been met. (Inferior Corneal Fluorescein Staining Using The Ora Calibra Scale), as per Results published in the Journal of Ocular Pharmacology and Therapeutics
01 Nov 2023 Primary endpoint has not been met, (Ocular Discomfort Using The Ora Calibra Scale), as per Results published in the Journal of Ocular Pharmacology and Therapeutics, as per Results published in the Journal of Ocular Pharmacology and Therapeutics
01 Nov 2023 Results published in the Journal of Ocular Pharmacology and Therapeutics

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com